CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To determine the relative risk of developing atopic dermatitis in infants fed a study formula based on whole goat milk compared to infants a study fo...
Valencia, Spain and 11 other locations
The main purpose of this study is to evaluate the effectiveness of 24 weeks of lebrikizumab in improving disease severity, signs, and symptoms in adu...
Phase 3
Valencia, Spain and 3 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Manises, València, Spain and 95 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Manises, Spain and 96 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Valencia, Spain and 536 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Valencia, Comunidad Valenciana, Spain and 536 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Valencia, Spain and 194 other locations
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate at...
Phase 3
Manises, Spain and 91 other locations
The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections \[SC\]) in combination with topical co...
Phase 3
Valencia, Spain and 62 other locations
This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...
Phase 2
Manises, Valencia, Spain and 137 other locations
Clinical trials
Research sites
Resources
Legal